Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Top Cited Papers
Open Access
- 2 April 2015
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 46 (1), 186-196
- https://doi.org/10.1183/09031936.00217614
Abstract
After introduction of the new international guidelines on idiopathic pulmonary fibrosis (IPF) in 2011, we investigated clinical management practices for patients with IPF according to physicians' diagnoses.A prospective, multicenter, noninterventional study with comprehensive quality measures including on-site source data verification was performed in Germany.502 consecutive patients (171 newly diagnosed, 331 prevalent; mean±sd age 68.7±9.4 years, 77.9% males) with a mean disease duration of 2.3±3.5 years were enrolled. IPF diagnosis was based on clinical assessments and high-resolution computed tomography (HRCT) in 90.2%, and on surgical lung biopsy combined with histology in 34.1% (lavage in 61.8%). The median 6-min walk distance was 320 m (mean 268±200 m). The mean forced vital capacity was 72±20% pred and diffusing capacity of the lung for carbon monoxide was 35±15% pred. No drugs were administered in 17.9%, oral steroids in 23.7%, N-acetylcysteine in 33.7%, pirfenidone in 44.2% and other drugs in 4.6% of patients. Only 2.8% of the cohort was listed for lung transplantation.IPF patients were diagnosed in line with the new guidelines. They had more severe disease than those enrolled in recent randomised controlled trials. In addition to HRCT, the frequency of lung biopsies was surprisingly high. Treatment patterns varied substantially.Keywords
Funding Information
- Boehringer Ingelheim
This publication has 37 references indexed in Scilit:
- Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the futureEuropean Respiratory Review, 2013
- Charakteristika und Versorgung der idiopathischen LungenfibroseDeutsche Medizinische Wochenschrift (1946), 2012
- Triple therapy in idiopathic pulmonary fibrosis: an alarming press releaseEuropean Respiratory Journal, 2012
- Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011European Respiratory Journal, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Influence of secular trends and sample size on reference equations for lung function testsEuropean Respiratory Journal, 2010
- The SF-36 and SGRQ: Validity and first look at minimum important differences in IPFRespiratory Medicine, 2010
- Challenges in pulmonary fibrosis: 8 {middle dot} The need for an international registry for idiopathic pulmonary fibrosisThorax, 2008
- Guidelines for good pharmacoepidemiology practices (GPP)Pharmacoepidemiology and Drug Safety, 2005
- BiasJournal of Epidemiology and Community Health, 2004